FDA Approves First Twice-a-Year HIV Prevention Shot
The FDA has approved the world’s only twice-a-year HIV prevention shot by Gilead Sciences, a potential global game-changer with access questions ahead.
HIVPrevention
Read More
Lenacapavir Named Science’s Breakthrough of the Year, Revolutionizing HIV Prevention
A new injectable HIV drug, lenacapavir, has been named Science’s Breakthrough of the Year for its innovative approach and potential to eliminate infections. Discover how it could change the fight against HIV/AIDS.